Which medications are most commonly associated with fixed drug eruption?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fixed Drug Eruption: Most Common Causative Medications

The most frequently implicated drugs in fixed drug eruption (FDE) are cotrimoxazole (trimethoprim-sulfamethoxazole), NSAIDs (particularly ibuprofen and naproxen), and antibiotics (especially tetracyclines and fluoroquinolones).

Primary Offending Agents

Sulfonamide Antibiotics (Most Common Overall)

  • Cotrimoxazole (TMP-SMX) is consistently the leading cause across multiple studies, accounting for 36-75% of FDE cases 1, 2, 3, 4
  • Sulfadiazine also implicated in 12.4% of cases 3
  • Important caveat: Delayed skin testing (intradermal and patch testing) has poor sensitivity for FDE caused by sulfonamides 5

NSAIDs (Increasingly Recognized, High Mortality Risk)

  • Nonsteroidal anti-inflammatory drugs cause 48.7% of generalized bullous FDE (GBFDE), the severe variant 6
  • Specific agents include:
    • Ibuprofen 7, 8
    • Naproxen sodium (12.5% of cases) 2
    • Metamizole/Dipyrone (9.3-9.5%) 1, 2, 3
    • Oxyphenbutazone (9 cases in one series) 1
    • Piroxicam, diclofenac sodium, indomethacin, mefenamic acid 4
  • Critical warning: NSAIDs are available over-the-counter in many countries, making them a significant public health risk for GBFDE, which carries 15.2% mortality 6

Antibiotics (Second Most Common Class)

  • Fluoroquinolones (particularly norfloxacin) were the most common cause in one recent study (56% of cases) 9
  • Tetracyclines cause 15.9% of FDE, with a distinctive pattern affecting only the glans penis 3
  • Other antibiotics: metronidazole, tinidazole, amoxicillin, ampicillin, erythromycin, clindamycin 4

Analgesics and Antipyretics

  • Paracetamol/acetaminophen (7.9-12%) 3, 4
  • Aspirin (1.7%) 3

Less Common but Documented Agents

  • Anticonvulsants: phenobarbitone 4
  • Antiparasitics: pyrantel pamoate, albendazole 4
  • Immunomodulators: levamizole (associated with constitutional symptoms) 3
  • Antifungals: griseofulvin 4
  • Others: allopurinol, orphenadrine, chlormezanone 4

Drug-Specific Clinical Patterns

Understanding these patterns helps identify the causative agent when drug history is unclear:

  • Cotrimoxazole: Predominantly affects male genitalia, lips (91%), trunk and limbs (89%), minimal mucosal involvement 2, 3
  • Tetracycline: Exclusively affects glans penis, sparing other sites 3
  • Naproxen: Predominantly affects lips and face 2
  • Dipyrone: Mainly causes FDE on trunk and extremities, sparing lips, genitalia, and mucosae 2, 3
  • Fluoroquinolones: Associated with both cutaneous (48%) and mucosal lesions (14%), most common cause of bullous and generalized bullous FDE 9

Critical Clinical Considerations

Latency period: Median onset is 24 hours (range 12-72 hours) for GBFDE 6, but first episodes average 6.5 days while subsequent episodes occur within 4.3 hours 9

Mortality risk: GBFDE has 15.2% mortality, significantly associated with older age 6. The widespread availability of over-the-counter NSAIDs poses particular risk.

Diagnostic confirmation: Oral provocation testing remains the only reliable method to confirm the causative drug and avoid false incrimination 1. However, skin testing has limited utility, particularly for delayed reactions 5.

Common pitfall: Patients may not report over-the-counter medication use (especially NSAIDs and ibuprofen), making diagnosis challenging 7, 8. Always specifically ask about all OTC medications, including those taken "as needed."

References

Research

Drugs causing fixed drug eruptions: confirmed by provocation tests.

Indian journal of dermatology, venereology and leprology, 2003

Research

Drug related clinical pattern in fixed drug eruption.

European journal of dermatology : EJD, 2000

Research

Drug-specific clinical pattern in fixed drug eruptions.

International journal of dermatology, 1991

Research

Drugs causing fixed eruptions: a study of 450 cases.

International journal of dermatology, 1998

Guideline

drug allergy: a 2022 practice parameter update.

Journal of Allergy and Clinical Immunology, 2022

Research

Generalized Bullous Fixed Drug Eruption: A Systematic Review.

The journal of allergy and clinical immunology. In practice, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.